Overall, the accumulating evidence positions NRN1 at the intersection of molecular neuroprotection and translational ophthalmology, offering hope for novel strategies to preserve and potentially restore vision in patients at risk of progressive optic neuropathies. This evidence concerns the gene NRN1 and optic nerve disorder.